Abstract:Proteolysis-targeting chimeras (PROTACs) are hetero-bifunctional molecules. They induce the degradation of a target protein by recruiting an E3 ligase to the target. The PROTAC can inactivate disease-related genes that are considered as understudied, thus has a great potential to be a new type of therapy for the treatment of incurable diseases. However, only hundreds of proteins have been experimentally tested if they are amenable to the PROTACs. It remains elusive what other proteins can be targeted by the PROTAC in the entire human genome. For the first time, we have developed an interpretable machine learning model PrePROTAC, which is based on a transformer-based protein sequence descriptor and random forest classification to predict genome-wide PROTAC-induced targets degradable by CRBN, one of the E3 ligases. In the benchmark studies, PrePROTAC achieved ROC-AUC of 0.81, PR-AUC of 0.84, and over 40% sensitivity at a false positive rate of 0.05, respectively. Furthermore, we developed an embedding SHapley Additive exPlanations (eSHAP) method to identify positions in the protein structure, which play key roles in the PROTAC activity. The key residues identified were consistent with our existing knowledge. We applied PrePROTAC to identify more than 600 novel understudied proteins that are potentially degradable by CRBN, and proposed PROTAC compounds for three novel drug targets associated with Alzheimer's disease. Author summary: Many human diseases remain incurable because disease-causing genes cannot by selectively and effectively targeted by small molecules. Proteolysis-targeting chimera (PROTAC), an organic compound that binds to both a target and a degradation-mediating E3 ligase, has emerged as a promising approach to selectively target disease-driving genes that are not druggable by small molecules. Nevertheless, not all of proteins can be accommodated by E3 ligases, and be effectively degraded. Knowledge on the degradability of a protein will be crucial for the design of PROTACs. However, only hundreds of proteins have been experimentally tested if they are amenable to the PROTACs. It remains elusive what other proteins can be targeted by the PROTAC in the entire human genome. In this paper, we propose an intepretable machine learning model PrePROTAC that takes advantage of powerful protein language modeling. PrePROTAC achieves high accuracy when evaluated by an external dataset which comes from different gene families from the proteins in the training data, suggesting the generalizability of PrePROTAC. We apply PrePROTAC to the human genome, and identify more than 600 understudied proteins that are potentially responsive to the PROTAC. Furthermore, we design three PROTAC compounds for novel drug targets associated with Alzheimer's disease.

ProtRAP: Predicting Lipid Accessibility Together with Solvent Accessibility of Proteins in One Run

MPRAP: An accessibility predictor for a-helical transmem-brane proteins that performs well inside and outside the membrane

Rapid proteome-wide prediction of lipid-interacting proteins through ligand-guided structural genomics

Tmp-Ssurface: A Deep Learning-Based Predictor For Surface Accessibility Of Transmembrane Protein Residues

E-pRSA: Embeddings Improve the Prediction of Residue Relative Solvent Accessibility in Protein Sequence

Membrane contact probability: an essential and predictive character for the structural and functional studies of membrane proteins

TMP- SSurface2: A Novel Deep Learning-Based Surface Accessibility Predictor for Transmembrane Protein Sequence

Prediction of Relative Solvent Accessibility Using Support Vector Regression

Role of solvent accessibility for aggregation-prone patches in protein folding

Division of Protein Surface Patches and Its Application in Protein Binding Site Prediction

ProtSolM: Protein Solubility Prediction with Multi-modal Features

ALipSol: An Attention-Driven Mixture-of-Experts Model for Lipophilicity and Solubility Prediction

APIS: accurate prediction of hot spots in protein interfaces by combining protrusion index with solvent accessibility

Prediction of protein solubility based on sequence physicochemical patterns and distributed representation information with DeepSoluE

Predicting RNA solvent accessibility from multi-scale context feature via multi-shot neural network

Elucidation of Genome-wide Understudied Proteins targeted by PROTAC-induced degradation using Interpretable Machine Learning

DeepSol: a deep learning framework for sequence‐based protein solubility prediction

Unbiased MD simulations identify lipid binding sites in lipid transfer proteins

Solvent Accessibility Promotes Rotamer Errors during Protein Modeling with Major Side-Chain Prediction Programs

E3-targetPred: Prediction of E3-Target Proteins Using Deep Latent Space Encoding

HydraProt: A New Deep Learning Tool for Fast and Accurate Prediction of Water Molecule Positions for Protein Structures